West Pharmaceutical Services Revenue 2010-2024 | WST

West Pharmaceutical Services annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • West Pharmaceutical Services revenue for the quarter ending September 30, 2024 was $0.747B, a 0.07% decline year-over-year.
  • West Pharmaceutical Services revenue for the twelve months ending September 30, 2024 was $2.876B, a 1.71% decline year-over-year.
  • West Pharmaceutical Services annual revenue for 2023 was $2.95B, a 2.18% increase from 2022.
  • West Pharmaceutical Services annual revenue for 2022 was $2.887B, a 1.95% increase from 2021.
  • West Pharmaceutical Services annual revenue for 2021 was $2.832B, a 31.89% increase from 2020.
West Pharmaceutical Services Annual Revenue
(Millions of US $)
2023 $2,950
2022 $2,887
2021 $2,832
2020 $2,147
2019 $1,840
2018 $1,717
2017 $1,599
2016 $1,509
2015 $1,400
2014 $1,421
2013 $1,368
2012 $1,266
2011 $1,192
2010 $1,105
2009 $1,056
West Pharmaceutical Services Quarterly Revenue
(Millions of US $)
2024-09-30 $747
2024-06-30 $702
2024-03-31 $695
2023-12-31 $732
2023-09-30 $747
2023-06-30 $754
2023-03-31 $717
2022-12-31 $709
2022-09-30 $687
2022-06-30 $771
2022-03-31 $720
2021-12-31 $731
2021-09-30 $707
2021-06-30 $724
2021-03-31 $671
2020-12-31 $580
2020-09-30 $548
2020-06-30 $527
2020-03-31 $492
2019-12-31 $471
2019-09-30 $456
2019-06-30 $470
2019-03-31 $444
2018-12-31 $423
2018-09-30 $432
2018-06-30 $448
2018-03-31 $416
2017-12-31 $416
2017-09-30 $398
2017-06-30 $398
2017-03-31 $388
2016-12-31 $382
2016-09-30 $377
2016-06-30 $388
2016-03-31 $362
2015-12-31 $360
2015-09-30 $345
2015-06-30 $360
2015-03-31 $336
2014-12-31 $350
2014-09-30 $356
2014-06-30 $369
2014-03-31 $347
2013-12-31 $343
2013-09-30 $342
2013-06-30 $345
2013-03-31 $339
2012-12-31 $322
2012-09-30 $304
2012-06-30 $325
2012-03-31 $316
2011-12-31 $295
2011-09-30 $294
2011-06-30 $308
2011-03-31 $295
2010-12-31 $277
2010-09-30 $271
2010-06-30 $282
2010-03-31 $275
2009-12-31 $293
2009-09-30 $259
2009-06-30 $261
2009-03-31 $242
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.024B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36